Answers are grounded in this paper and cite their sources.
High-grade astrocytoma with piloid features (HGAP) is a recently defined brain tumor entity primarily diagnosed via DNA methylation profiling due to its histological overlap with glioblastoma and pilocytic astrocytoma. We report a 26-year-old man with neurofibromatosis type 1 (NF1) presenting with a high-grade midline lesion involving the thalamus and mesencephalon. Histopathological examination demonstrated a high-grade glial neoplasm with loss of ATRX expression by immunohistochemistry. While HGAP typically occurs in the posterior fossa, NF1-associated cases show a marked predilection for midline locations, complicating the differential diagnosis with other high-grade gliomas. In this case, DNA methylation profiling confirmed the diagnosis with high confidence. Prognostically, HGAP demonstrates an intermediate survival profile, with a 5-year overall survival rate of approximately 50%, which is superior to IDH-wild-type glioblastoma but inferior to conventional pilocytic astrocytoma. Although standardized treatment guidelines are lacking, identifying targetable molecular alterations remains essential for management.
No takes yet. Share an insight, caveat, or question.
Söylemez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: